Citations

Showing 10 of 108119 citations.

Chasing the storm: Recruiting non‐hospitalized patients for a multi‐site randomized controlled trial in the United States during the COVID‐19 pandemic
Hu, Kelly, Huber, Melanie , Daly, M d. B., Kirby, Ruth , Rosenberg, Yves , Joshi, Avni Y. , Bassevitch, Zohar, Joshi, Avni, Tardif, Jean‐Claude , Huber, Melanie, Langford, Aisha T , Hochman, Judith S. , Pillinger, Michael H. , Shah, Binita

Mayo Clinic

Clinical and Translational Science | December 25, 2021 | Volume: 15 | Issue: 4 | Pages: 831-837

10.1111/cts.13211 | PMID 34953032 Get It

AbstractRandomized controlled trials (RCTs) remain the gold standard to evaluate clinical interventions, producing the highest level of evidence while minimizing potential bias. Inadequate recruitment is a commonly encountered problem that undermines the completion and generalizability of RCTs—and is even more challenging when enrolling amidst a pandemic. Here, we reflect on our experiences with virtual recruitment of non‐hospitalized patients in the United States for ColCorona, an international, multicenter, randomized, placebo‐controlled coronavirus disease 2019 (COVID‐19) drug trial. Recruitment challenges during a pandemic include constraints created by shelter‐in‐place policies and targeting enrollment according to national and local fluctuations in infection rate. Presenting a study to potential participants who are sick with COVID‐19 and may be frightened, overwhelmed, or mistrusting of clinical research remains a challenge. Strategies previously reported to improve recruitment include transparency, patient and site education, financial incentives, and person‐to‐person outreach. Active measures taken during ColCorona to optimize United States recruitment involved rapid expansion of sites, adjustment of recruitment scripts, assessing telephone calls versus text messages for initial contact with participants, institutional review board‐approved financial compensation, creating an infrastructure to systematically identify potentially eligible patients, partnering with testing sites, appealing to both self‐interest and altruism, and large‐scale media efforts with varying degrees of success.
Does Proximal Row Carpectomy Improve Union in Wrist Arthrodesis? A Retrospective Cohort Study
Bartoletta, John J. , Rioux-Forker, Dana , Patel, Raahil , Hinchcliff, Katharine M. , Shin, Alexander Y. , Rhee, Peter C. , Patel, Raahil S , Shin, Alexander Y , Hinchcliff, Katharine

Mayo Clinic

Journal of Wrist Surgery | December 24, 2021 | Volume: 11 | Issue: 04 | Pages: 344-352

10.1055/s-0041-1740400 | PMID 35971476 Get It

Abstract Background Some surgeons advocate for concomitant proximal row carpectomy (PRC) with total wrist arthrodesis (TWA), though there are limited data to support or oppose this view. Questions/Purposes Does concomitant PRC improve rates of union, revision, hardware loosening, hardware failure, and hardware removal in TWA? Patients and Methods A retrospective cohort study of patients who underwent TWA with and without concomitant PRC between January 2008 and December 2018 was undertaken. Patients were included if they underwent TWA using a dorsal spanning plate. Patients were excluded if they underwent partial wrist arthrodesis, revision TWA, or TWA with nondorsal spanning plate fixation. Results A total of 183 wrists in 180 patients were included in the study, 96 (52.5%) in the TWA only and 87 (47.5%) in the TWA + PRC groups. Median clinical and radiographic follow-up was 18.0 months (3.0–133.0 months) in the TWA + PRC group and 18.5 months (2.0–126.0 months) in the TWA only group (p = 0.907). No difference in nonunion (TWA + PRC: 13/87 [14.9%], TWA only: 18/96 [18.8%], odds ratio: 0.76, p = 0.494), revision (TWA + PRC: 5/87 [5.75%], TWA only: 8/96 [8.33%], hazard ratio [HR]: 0.73, p = 0.586), loosening (TWA + PRC: 4/87 [4.60%], TWA only: 6/96 [6.25%], HR: 0.74, p = 0.646), failure (TWA + PRC: 5/87 [5.75%], TWA only: 4/96 [4.17%], HR: 1.55, p = 0.530), and removal (TWA + PRC: 12/87 [13.8%], TWA only: 16/96 [16.7%], HR: 0.84, p = 0.634) were identified. Conclusion Concomitant PRC might not improve rates of union or diminish complications in patient undergoing TWA. The role of PRC and the rationale for its use in TWA need to be individualized and discussed with patients prior to surgery. Level of Evidence This is a Level IV, therapeutic study.
Machine learning in primary biliary cholangitis: A novel approach for risk stratification
Gerussi, Alessio , Verda, Damiano , Komori, Atsumasa , Inao, Mie , Mochida, Satoshi , Yoshiji, Hitoshi , Lindor, Keith D. , Cazzagon, Nora , Floreani, Annarosa , Marzioni, Marco , Cristoferi, Laura , Valsecchi, Maria Grazia , Hansen, Bettina E. , Carbone, Marco , Namisaki, Tadashi , Lindor, K D , Marzioni, Marco , Vespasiani-Gentilucci, Umberto , Cristoferi, Laura , Tanaka, Atsushi , Invernizzi, Pietro , Bernasconi, Davide P , Carbone, Marco , Abe, Masanori , Hirschfield, Gideon M. , Parés, Albert , Corpechot, Christophe , Alvaro, Domenico , Muselli, Marco , Hansen, Bettina E. , Invernizzi, Pietro

Mayo Clinic

Liver International | December 24, 2021 | Volume: 42 | Issue: 3 | Pages: 615-627

10.1111/liv.15141 | PMID 34951722 Get It

AbstractBackground & AimsMachine learning (ML) provides new approaches for prognostication through the identification of novel subgroups of patients. We explored whether ML could support disease sub‐phenotyping and risk stratification in primary biliary cholangitis (PBC).MethodsML was applied to an international dataset of PBC patients. The dataset was split into a derivation cohort (training set) and a validation cohort (validation set), and key clinical features were analysed. The outcome was a composite of liver‐related death or liver transplantation. ML and standard survival analysis were performed.ResultsThe training set was composed of 11,819 subjects, while the validation set was composed of 1,069 subjects. ML identified four clusters of patients characterized by different phenotypes and long‐term prognosis. Cluster 1 (n = 3566) included patients with excellent prognosis, whereas Cluster 2 (n = 3966) consisted of individuals at worse prognosis differing from Cluster 1 only for albumin levels around the limit of normal. Cluster 3 (n = 2379) included young patients with florid cholestasis and Cluster 4 (n = 1908) comprised advanced cases. Further sub‐analyses on the dynamics of albumin within the normal range revealed that ursodeoxycholic acid‐induced increase of albumin >1.2 x lower limit of normal (LLN) is associated with improved transplant‐free survival.ConclusionsUnsupervised ML identified four novel groups of PBC patients with different phenotypes and prognosis and highlighted subtle variations of albumin within the normal range. Therapy‐induced increase of albumin >1.2 x LLN should be considered a treatment goal.
Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt
Shen, Renhui, Richard, Seth , Liu, Yu , Jalalirad, Mohammad, Cleary, Margot P. , D’Assoro, Antonio B., Gradilone, Sergio A. , Yang, Da‐Qing , D'Assoro, Antonio B, Gradilone, Sergio A , Cao, Wei

Mayo Clinic

Oncology Reports | December 24, 2021 | Volume: 47 | Issue: 2 | Pages: No page available

10.3892/or.2021.8252 | PMID 34958116 Get It

Targeted Interventions in Tourette’s using Advanced Neuroimaging and Stimulation (TITANS): study protocol for a double-blind, randomised controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area in children with Tourette’s
Kahl, Cynthia , Swansburg, Rose , Kirton, Adam , Pringsheim, Tamara , Wilcox, Gabrielle , Zewdie, Ephrem , Harris, Ashley D. , Nettel‐Aguirre, Alberto , Chenji, Sneha , Macmaster, Frank P , Pringsheim, Tamara , Croarkin, Paul E. , MacMaster, Frank P.

Mayo Clinic

BMJ Open | December 24, 2021 | Volume: 11 | Issue: 12 | Pages: e053156

10.1136/bmjopen-2021-053156 | PMID 34952879 Get It

Introduction Tourette’s syndrome (TS) affects approximately 1% of children. This study will determine the efficacy and safety of paired comprehensive behavioural intervention for tics (CBIT) plus repetitive transcranial magnetic stimulation (rTMS) treatment in children with Tourette’s syndrome. We hypothesise that CBIT and active rTMS to the supplementary motor area (SMA) will (1) decrease tic severity, and (2) be associated with changes indicative of enhanced neuroplasticity (eg, changes in in vivo metabolite concentrations and TMS neurophysiology measures). Methods and analysis This study will recruit 50 youth with TS, aged 6–18 for a phase II, double-blind, block randomised, sham-controlled trial comparing active rTMS plus CBIT to sham rTMS plus CBIT in a 1:1 ratio. The CBIT protocol is eight sessions over 10 weeks, once a week for 6 weeks and then biweekly. The rTMS protocol is 20 sessions of functional MRI-guided, low-frequency (1 Hz) rTMS targeted to the bilateral SMA over 5 weeks (weeks 2–6). MRI, clinical and motor assessments and neurophysiological evaluations including motor mapping will be performed 1 week before CBIT start, 1 week after rTMS treatment and 1 week after CBIT completion. The primary outcome measure is Tourette’s symptom change from baseline to post-CBIT treatment, as measured by the Yale Global Tic Severity Scale. Secondary outcomes include changes in imaging, neurophysiological and behavioural markers. Ethics and dissemination Ethical approval by the Conjoint Health Research Ethics Board (REB18-0220). The results of this study will be published in peer-reviewed scientific journals, on ClinicalTrials.gov and shared with the Tourette and OCD Alberta Network. The results will also be disseminated through the Alberta Addictions and Mental Health Research Hub. Trial registration NCT03844919 .
Commentary on: Facial Arterial Variations in Asians: A Study on Computed Tomographic Angiography
Cotofana, Sebastian , Lowrey, Nicola , Frank, Konstantin , Alfertshofer, Michael , Antezana, Luis A. , Freytag, Lysander, Velthuis, Peter J. , Alfertshofer, Michael , Antezana, Luis , Cotofana, Sebastian , Frank, Konstantin , Moellhoff, Nicholas

Mayo Clinic

Aesthetic Surgery Journal | December 24, 2021 | Volume: 42 | Issue: 5 | Pages: 535-536

10.1093/asj/sjab405 | PMID 34951452 Get It

Influence of liver stiffness heterogeneity on staging fibrosis in patients with nonalcoholic fatty liver disease
Kawamura, Nobuyoshi , Imajo, Kento , Kalutkiewicz, Kyle, Nagai, Koki , Iwaki, Michihiro , Kobayashi, Takashi , Nogami, Asako , Honda, Yasushi , Ogawa, Yuji, Higurashi, Takuma , Takahashi, Hirokazu , Saito, Satoru , Aishima, Shinichi , Hayashi, Hideki , Kalutkiewicz, Kyle J, Takahashi, Hirokazu , Kessoku, Takaomi , Hosono, Kunihiro , Yoneda, Masato , Toyoda, Hidenori , Sumida, Yoshio , Ehman, Richard L. , Nakajima, Atsushi

Mayo Clinic

Hepatology | December 24, 2021 | Volume: 76 | Issue: 1 | Pages: 186-195

10.1002/hep.32302 | PMID 34951726 Get It

Abstract Background and Aims Despite that hepatic fibrosis often affects the liver globally, spatial distribution can be heterogeneous. This study aimed to investigate the effect of liver stiffness (LS) heterogeneity on concordance between MR elastography (MRE)‐based fibrosis staging and biopsy staging in patients with NAFLD. Approach and Results We retrospectively evaluated data from 155 NAFLD patients who underwent liver biopsy and 3 Tesla MRE and undertook a retrospective validation study of 169 NAFLD patients at three hepatology centers. Heterogeneity of stiffness was assessed by measuring the range between minimum and maximum MRE‐based LS measurement (LSM). Variability of LSM was defined as the stiffness range divided by the maximum stiffness value. The cohort was divided into two groups (homogenous or heterogeneous), according to whether variability was below or above the average for the training cohort. Based on histopathology and receiver operating characteristic (ROC) analysis, optimum LSM thresholds were determined for MRE‐based fibrosis staging of stage 4 (4.43, kPa; AUROC, 0.89) and stage ≥3 (3.93, kPa; AUROC, 0.89). In total, 53 had LSM above the threshold for stage 4. Within this group, 30 had a biopsy stage of <4. In 86.7% of these discordant cases, variability of LSM was classified as heterogeneous. In MRE‐based LSM stage ≥3, 88.9% of discordant cases were classified as heterogeneous. Results of the validation cohort were similar to those of the training cohort. Conclusions Discordance between biopsy‐ and MRE‐based fibrosis staging is associated with heterogeneity in LSM, as depicted with MRE.
Implementation of an Expressive Writing Intervention for Adolescents During Inpatient Psychiatric Hospitalization
Taniguchi, Yuko , Schlief, Mason, Bright, Jered, Simon, Sue, Leffler, Jarrod M. , Simon, Sue

Mayo Clinic

Adolescent Psychiatry | December 24, 2021 | Volume: 12 | Issue: 1 | Pages: 23-37

10.2174/2210676612666211222104647 Get It

BACKGROUND: Given the high rates of mental health concerns and communication difficulties for adolescents a treatment intervention to allow for effective expression may be therapeutic. One of the leading writing practices is Pennebaker’s Expressive Writing (EW) intervention. EW involves individuals writing about their feelings and thoughts regarding negative life experiences. Benefits of EW include a reduction of psychological symptoms and doctor visits, and better adjustment. OBJECTIVE: To examine the role of using EW and creative writing as a group intervention for youth admitted to an inpatient psychiatric hospital (IPH) METHODS: The current study evaluated participant engagement in a 3-day EW activity facilitated by nurses and graduate students on the IPH unit under the supervision of the IPH unit nurse manager and course instructor. Participants included 23 youth between 12- and 18-years-old RESULTS: Of the 23 participants 49.69% discussed vivid descriptions of illness, 24.5% discussed negative emotions, 20.25% included casual explanation, 5.52% discussed polarized view, and 16.56% discussed their desires, wishes, and goals. The response rate of clinician’s review of the EW content included 58% of clinician’s coding was on the patient’s current state, 24% was on causal explanations, and 18% was on treatment options. CONCLUSION: The current EW intervention facilitated by nursing staff and graduate students in an IPH was found to be engaged in by participants and provide an additional therapeutic resource to participants. EW may foster patient communication with staff about their functioning, mental health concerns, and treatment needs.
Exome Sequencing Highlights a Potential Role for Concealed Cardiomyopathies in Youthful Sudden Cardiac Death
Neves, Raquel , Tester, David J. , Simpson, Michael A. , Behr, Elijah R. , Ackerman, Michael J. , Giudicessi, John R. , Behr, Elijah Raphael , Neves, Raquel Almeida Lopes , Neves, Raquel, Tester, David J, Simpson, Michael A, Behr, Elijah R, Ackerman, Michael J, Giudicessi, John R

Mayo Clinic

Circulation: Genomic and Precision Medicine | December 24, 2021 | Volume: 15 | Issue: 1 | Pages: No page available

10.1161/circgen.121.003497 | PMID 34949102 Get It

Background: Sudden cardiac arrest (SCA) and sudden unexplained death (SUD) are feared sequelae of many genetic heart diseases. In rare circumstances, pathogenic variants in cardiomyopathy-susceptibility genes may result in electrical instability leading to SCA/SUD before any structural manifestations of underlying cardiomyopathy are evident. Methods: Collectively, 38 unexplained SCA survivors (21 males; mean age at SCA 26.4±13.1 years), 68 autopsy-inconclusive SUD cases (46 males; mean age at death 20.4±9.0 years) without disease-causative variants in the channelopathy genes, and 973 ostensibly healthy controls were included. Following exome sequencing, ultrarare (minor allele frequency ≤0.00005 in any ethnic group within Genome Aggregation Database [gnomAD, N=141 456 individuals]) nonsynonymous variants identified in 24 Clinical Genome Resource adjudicated definitive/strong evidence cardiomyopathy-susceptibility genes were analyzed. Eligible variants were adjudicated as pathogenic, likely pathogenic, or variant of uncertain significance in accordance with current American College of Medical Genetics and Genomics guidelines. Results: Overall, 7 out of 38 (18.4%) SCA survivors and 14 out of 68 (20.5%) autopsy-inconclusive, channelopathic-negative SUD cases had at least one pathogenic/likely pathogenic or a variant of uncertain significance nonsynonymous variant within a strong evidence, cardiomyopathy-susceptibility gene. Following American College of Medical Genetics and Genomics criterion variant adjudication, a pathogenic or likely pathogenic variant was identified in 3 out of 38 (7.9%; P =0.05) SCA survivors and 8 out of 68 (11.8%; P =0.0002) autopsy-inconclusive SUD cases compared to 20 out of 973 (2.1%) European controls. Interestingly, the yield of pathogenic/likely pathogenic variants was significantly greater in autopsy-inconclusive SUD cases with documented interstitial fibrosis (4/11, 36%) compared with only 4 out of 57 (7%, P <0.02) SUD cases without ventricular fibrosis. Conclusions: Our data further supports the inclusion of strong evidence cardiomyopathy-susceptibility genes on the genetic testing panels used to evaluate unexplained SCA survivors and autopsy-inconclusive/negative SUD decedents. However, to avoid diagnostic miscues, the careful interpretation of genetic test results in patients without overt phenotypes is vital.
Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration
Ortmayr, Gregor , Brunnthaler, Laura, Huber, Heidemarie, Santol, Jonas , Rumpf, Benedikt , Najarnia, S. , Smoot, Rory L. , Ammon, Daphni , Sorz, Thomas , Fritsch, Fabian, Schodl, Michael, Voill‐Glaninger, Astrid , Weitmayr, Barbara, Födinger, Manuela, Klimpfinger, M., Assinger, Alice , Pereyra, David , Starlinger, Patrick , Smoot, Rory L , Assinger, Alice , Santol, Jonas , Pereyra, David , Gruenberger, Thomas , Mikulits, Wolfgang , Starlinger, Patrick

Mayo Clinic

Hepatology Communications | December 24, 2021 | Volume: 6 | Issue: 3 | Pages: 576-592

10.1002/hep4.1832 | PMID 34951136 Get It

AXL and its corresponding ligand growth arrest–specific 6 (GAS‐6) are critically involved in hepatic immunomodulation and regenerative processes. Pleiotropic inhibitory effects on innate inflammatory responses might essentially involve the shift of macrophage phenotype from a pro‐inflammatory M1 to an anti‐inflammatory M2. We aimed to assess the relevance of the AXL/GAS‐6‐pathway in human liver regeneration and, consequently, its association with clinical outcome after hepatic resection. Soluble AXL (sAXL) and GAS‐6 levels were analyzed at preoperative and postoperative stages in 154 patients undergoing partial hepatectomy and correlated with clinical outcome. Perioperative dynamics of interleukin (IL)‐6, soluble tyrosine‐protein kinase MER (sMerTK), soluble CD163 (sCD163), and cytokeratin (CK) 18 were assessed to reflect pathophysiological processes. Preoperatively elevated sAXL and GAS‐6 levels predicted postoperative liver dysfunction (area under the curve = 0.721 and 0.722; P < 0.005) and worse clinical outcome. These patients failed to respond with an immediate increase of sAXL and GAS‐6 upon induction of liver regeneration. Abolished AXL pathway response resulted in a restricted increase of sCD163, suggesting a disrupted phenotypical switch to regeneratory M2 macrophages. No association with sMerTK was observed. Concomitantly, a distinct association of IL‐6 levels with an absent increase of AXL/GAS‐6 signaling indicated pronounced postoperative inflammation. This was further supported by increased intrahepatic secondary necrosis as reflected by CK18M65. sAXL and GAS‐6 represent not only potent and easily accessible preoperative biomarkers for the postoperative outcome but also AXL/GAS‐6 signaling might be of critical relevance in human liver regeneration. Refractory AXL/GAS‐6 signaling, due to chronic overactivation/stimulation in the context of underlying liver disease, appears to abolish their immediate release following induction of liver regeneration, causing overwhelming immune activation, presumably via intrahepatic immune regulation.